Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy [15]

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 1, 2003, Pages 202-203

  Moyenuddin, Munshi ^a   Ohl, Christopher A ^a   Williamson, John C ^a   Peacock, James E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Disseminated; Oxacillin resistant Staphylocuccus aureus

Indexed keywords

COLCHICINE; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LINEZOLID; LIVER ENZYME; OXACILLIN; RIFAMPICIN; ROFECOXIB; VANCOMYCIN;

ABSCESS; AGED; BACKACHE; BLOOD CULTURE; CASE REPORT; DEBRIDEMENT; DISEASE COURSE; DISKITIS; FEMALE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LETTER; LIVER TOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; PAIN; RASH; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYMPTOMATOLOGY; SYNOVIAL FLUID; TISSUE CULTURE; TREATMENT OUTCOME;

AGED; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; OXACILLIN; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VIRGINIAMYCIN;

EID: 0037256641     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg025     Document Type: Letter

References (6)

1. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
2. Livermore, D. M. (2000). Antibiotic resistance in staphylococci. International Journal of Antimicrobial Agents 16, S3-10.
3. Paradisi, F., Corti, G. & Messeri, D. (2001). Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics. Medical Clinics of North America 85, 1-17.
4. Gugliotta, J. J., Critchley, I. A., Draghi, D. C., Karginova, E., Karlowsky, J. A. & Sahm, D. F. (2001). Synergistic killing of oxacillin-resistant S. aureus by quinupristin-dalfopristin and vancomycin. In Program and Abstracts of the Forty-first Interscience, Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract E-328, p. 169. American Society for Microbiology, Washington, DC, USA.
5. Pavie, J., Zarrouk, V., Lefort, A., Garry, L., Leclercq, R., Carbon, C. et al. (2000). Activity of combination of quinupristin-dalfopristin (Q-D) and vancomycin (Vm) in vitro and in experimental endocarditis due to Staphylococcus aureus susceptible or resistant to quinupristin. In Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 2000. Abstract 1006, p. 57. American Society for Microbiology, Washington, DC, USA.
6. Allen, G. P., Cha, R. & Rybak, M. J. (2002). In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy 46, 2606-12.